on 18 Oct 2023
Last Applicant/ Owned by
NGM BIOPHARMACEUTICALS INC.
333 Oyster Point BoulevardSouth San Francisco CA 94080
US
Serial Number
2224052 filed on 15th Sept 2022
Correspondent Address
FASKEN MARTINEAU DUMOULIN LLP
333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO
ONTARIO
CA
M5H2T6
Trademark usage description
providing medical information relating to cancer, retinal diseases and liver and metabolic diseases. pharmaceutical preparations. providing medical Read More11
11
11
2224052
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 18th Oct 2023 | Search Recorded |
Submitted for opposition 20 on 18th Oct 2023 | Examiner's First Report |
Submitted for opposition 223 on 18th Oct 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 25th Sept 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 19th Dec 2022 | Agent Changed |
Submitted for opposition 257 on 24th Nov 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 23rd Nov 2022 | Formalized |
Submitted for opposition 1 on 23rd Nov 2022 | Created |
Submitted for opposition 228 on 15th Sept 2022 | International Registration |
Submitted for opposition 30 on 15th Sept 2022 | Filed |